CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 1-benzylpiperazine
Accession: CHEBI:83537
browse the term
Definition: A tertiary amino compound that is piperazine substituted by a benzyl group at position 1. It is a serotonergic agonist used as a recreational drug.
Synonyms: related_synonym: BZP; Benzylpiperazine; Formula=C11H16N2; InChI=1S/C11H16N2/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13/h1-5,12H,6-10H2; InChIKey=IQXXEPZFOOTTBA-UHFFFAOYSA-N; N-Benzylpiperazine; SMILES=C(N1CCNCC1)c1ccccc1
alt_id: MESH:C461488
xref: CAS:2759-28-6
xref_mesh: MESH:C006737
xref: PMID:23685794; PMID:24486525; Reaxys:141624; Wikipedia:Benzylpiperazine
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of AASS mRNA
CTD
PMID:26821219
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
EXP
N-benzylpiperazine results in increased expression of ACAT2 mRNA
CTD
PMID:26821219
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Acsl3
acyl-CoA synthetase long-chain family member 3
increases expression
EXP
N-benzylpiperazine results in increased expression of ACSL3 mRNA
CTD
PMID:26821219
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:80,115,112...80,164,627
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
decreases expression
EXP
N-benzylpiperazine results in decreased expression of ACSM5 mRNA
CTD
PMID:26821219
NCBI chr 1:183,302,241...183,328,175
Ensembl chr 1:173,863,041...173,898,588
G
B4galt1
beta-1,4-galactosyltransferase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of B4GALT1 mRNA
CTD
PMID:26821219
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:55,935,615...55,982,461
G
Bbox1
gamma-butyrobetaine hydroxylase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BBOX1 mRNA
CTD
PMID:26821219
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
G
Bhmt
betaine-homocysteine S-methyltransferase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BHMT mRNA
CTD
PMID:26821219
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of BHMT2 mRNA
CTD
PMID:26821219
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
G
Cables1
Cdk5 and Abl enzyme substrate 1
increases expression
EXP
N-benzylpiperazine results in increased expression of CABLES1 mRNA
CTD
PMID:26821219
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
G
Cat
catalase
increases activity
ISO
1-benzylpiperazine results in increased activity of CAT protein
CTD
PMID:28874085
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Csrp3
cysteine and glycine rich protein 3
increases expression
EXP
N-benzylpiperazine results in increased expression of CSRP3 mRNA
CTD
PMID:26821219
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP2A1 mRNA
CTD
PMID:26821219
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP2E1 mRNA
CTD
PMID:26821219
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4A1 mRNA
CTD
PMID:26821219
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4A3 mRNA
CTD
PMID:26821219
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
G
Cyp4f4
cytochrome P450, family 4, subfamily f, polypeptide 4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP4F4 mRNA
CTD
PMID:26821219
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
G
Cyp51
cytochrome P450, family 51
increases expression
EXP
N-benzylpiperazine results in increased expression of CYP51 mRNA
CTD
PMID:26821219
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of CYP8B1 mRNA
CTD
PMID:26821219
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of DPYD mRNA
CTD
PMID:26821219
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:206,609,122...207,474,982
G
Dpysl2
dihydropyrimidinase-like 2
increases expression
EXP
N-benzylpiperazine results in increased expression of DPYSL2 mRNA
CTD
PMID:26821219
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:41,005,551...41,111,829
G
Eepd1
endonuclease/exonuclease/phosphatase family domain containing 1
increases expression
EXP
N-benzylpiperazine results in increased expression of EEPD1 mRNA
CTD
PMID:26821219
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of EHHADH mRNA
CTD
PMID:26821219
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Fads1
fatty acid desaturase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of FADS1 mRNA
CTD
PMID:26821219
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fasn
fatty acid synthase
increases expression
EXP
N-benzylpiperazine results in increased expression of FASN mRNA
CTD
PMID:26821219
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fbp1
fructose-bisphosphatase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of FBP1 mRNA
CTD
PMID:26821219
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of FDFT1 mRNA
CTD
PMID:26821219
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
increases expression
EXP
N-benzylpiperazine results in increased expression of FDPS mRNA
CTD
PMID:26821219
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Flcn
folliculin
increases expression
EXP
N-benzylpiperazine results in increased expression of FLCN mRNA
CTD
PMID:26821219
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
G
Ftcd
formimidoyltransferase cyclodeaminase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of FTCD mRNA
CTD
PMID:26821219
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of G6PC1 mRNA
CTD
PMID:26821219
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
ISO
1-benzylpiperazine analog inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 1-benzylpiperazine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
CTD
PMID:26344803
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
G
Gpnmb
glycoprotein nmb
increases expression
EXP
N-benzylpiperazine results in increased expression of GPNMB mRNA
CTD
PMID:26821219
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gstt3
glutathione S-transferase, theta 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of GSTT3 mRNA
CTD
PMID:26821219
NCBI chr20:12,875,184...12,882,540
Ensembl chr20:12,874,854...12,882,599
G
Gys2
glycogen synthase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of GYS2 mRNA
CTD
PMID:26821219
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of HAO2 mRNA
CTD
PMID:26821219
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
N-benzylpiperazine results in increased expression of HMGCR mRNA
CTD
PMID:26821219
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of HMGCS1 mRNA
CTD
PMID:26821219
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of HMGCS2 mRNA
CTD
PMID:26821219
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of IDI1 mRNA
CTD
PMID:26821219
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Il1r2
interleukin 1 receptor type 2
increases expression
EXP
N-benzylpiperazine results in increased expression of IL1R2 mRNA
CTD
PMID:26821219
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Insig1
insulin induced gene 1
increases expression
EXP
N-benzylpiperazine results in increased expression of INSIG1 mRNA
CTD
PMID:26821219
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Kynu
kynureninase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of KYNU mRNA
CTD
PMID:26821219
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Mcm6
minichromosome maintenance complex component 6
increases expression
EXP
N-benzylpiperazine results in increased expression of MCM6 mRNA
CTD
PMID:26821219
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:39,826,763...39,851,960
G
Mdh1
malate dehydrogenase 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of MDH1 mRNA
CTD
PMID:26821219
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP
N-benzylpiperazine results in increased expression of MSMO1 mRNA
CTD
PMID:26821219
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Ndrg1
N-myc downstream regulated 1
increases expression
EXP
N-benzylpiperazine results in increased expression of NDRG1 mRNA
CTD
PMID:26821219
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
EXP
N-benzylpiperazine results in decreased expression of NR1I3 mRNA
CTD
PMID:26821219
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrg1
neuregulin 1
increases expression
EXP
N-benzylpiperazine results in increased expression of NRG1 mRNA
CTD
PMID:26821219
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
EXP
N-benzylpiperazine results in increased expression of PCSK9 mRNA
CTD
PMID:26821219
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
EXP
N-benzylpiperazine results in increased expression of PDP2 mRNA
CTD
PMID:26821219
NCBI chr19:386,408...394,068
Ensembl chr19:386,406...394,074
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
EXP
N-benzylpiperazine results in increased expression of PEA15 mRNA
CTD
PMID:26821219
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pgr
progesterone receptor
increases expression
ISO
1-benzylpiperazine results in increased expression of PGR mRNA
CTD
PMID:23026265
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
G
Rab30
RAB30, member RAS oncogene family
increases expression
EXP
N-benzylpiperazine results in increased expression of RAB30 mRNA
CTD
PMID:26821219
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
G
Rab32
RAB32, member RAS oncogene family
increases expression
EXP
N-benzylpiperazine results in increased expression of RAB32 mRNA
CTD
PMID:26821219
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rhoq
ras homolog family member Q
increases expression
EXP
N-benzylpiperazine results in increased expression of RHOQ mRNA
CTD
PMID:26821219
NCBI chr 6:7,613,632...7,652,047
Ensembl chr 1:106,622,141...106,623,699
G
Rnf145
ring finger protein 145
increases expression
EXP
N-benzylpiperazine results in increased expression of RNF145 mRNA
CTD
PMID:26821219
NCBI chr10:29,507,779...29,552,153
Ensembl chr10:29,011,548...29,050,781
G
Rragd
Ras-related GTP binding D
increases expression
EXP
N-benzylpiperazine results in increased expression of RRAGD mRNA
CTD
PMID:26821219
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SLC10A1 mRNA
CTD
PMID:26821219
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc38a7
solute carrier family 38, member 7
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC38A7 mRNA
CTD
PMID:26821219
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a10
solute carrier family 39 member 10
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC39A10 mRNA
CTD
PMID:26821219
NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:54,876,141...54,960,325
G
Slc6a6
solute carrier family 6 member 6
increases expression
EXP
N-benzylpiperazine results in increased expression of SLC6A6 mRNA
CTD
PMID:26821219
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SLCO1A2 mRNA
CTD
PMID:26821219
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Sod1
superoxide dismutase 1
increases activity
ISO
1-benzylpiperazine results in increased activity of SOD1 protein
CTD
PMID:28874085
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
increases expression
EXP
N-benzylpiperazine results in increased expression of SPTLC2 mRNA
CTD
PMID:26821219
NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:106,950,949...107,031,542
G
Sqle
squalene epoxidase
increases expression
EXP
N-benzylpiperazine results in increased expression of SQLE mRNA
CTD
PMID:26821219
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
EXP
N-benzylpiperazine results in increased expression of SREBF1 mRNA
CTD
PMID:26821219
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stard4
StAR-related lipid transfer domain containing 4
increases expression
EXP
N-benzylpiperazine results in increased expression of STARD4 mRNA
CTD
PMID:26821219
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stk10
serine/threonine kinase 10
increases expression
EXP
N-benzylpiperazine results in increased expression of STK10 mRNA
CTD
PMID:26821219
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Stx3
syntaxin 3
increases expression
EXP
N-benzylpiperazine results in increased expression of STX3 mRNA
CTD
PMID:26821219
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
G
Sult2a6
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
decreases expression
EXP
N-benzylpiperazine results in decreased expression of SULT2A6 mRNA
CTD
PMID:26821219
NCBI chr 1:74,911,097...74,962,239
Ensembl chr 1:74,911,100...75,508,134
G
Tecpr1
tectonin beta-propeller repeat containing 1
increases expression
EXP
N-benzylpiperazine results in increased expression of TECPR1 mRNA
CTD
PMID:26821219
NCBI chr12:10,391,587...10,420,462
Ensembl chr12:10,391,696...10,419,611
G
Tff1
trefoil factor 1
increases expression
ISO
1-benzylpiperazine results in increased expression of TFF1 mRNA
CTD
PMID:23026265
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
G
Tm4sf4
transmembrane 4 L six family member 4
decreases expression
EXP
N-benzylpiperazine results in decreased expression of TM4SF4 mRNA
CTD
PMID:26821219
NCBI chr 2:141,570,321...141,621,263
Ensembl chr 2:141,481,902...141,621,200
G
Trim59
tripartite motif-containing 59
increases expression
EXP
N-benzylpiperazine results in increased expression of TRIM59 mRNA
CTD
PMID:26821219
NCBI chr 2:155,579,183...155,593,450
Ensembl chr 2:153,268,584...153,281,031
G
Ttc36
tetratricopeptide repeat domain 36
decreases expression
EXP
N-benzylpiperazine results in decreased expression of TTC36 mRNA
CTD
PMID:26821219
NCBI chr 8:45,112,737...45,116,345
G
Urad
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase
decreases expression
EXP
N-benzylpiperazine results in decreased expression of URAD mRNA
CTD
PMID:26821219
NCBI chr12:7,709,278...7,718,925
Ensembl chr12:7,709,312...7,718,923
G
Usp2
ubiquitin specific peptidase 2
decreases expression
EXP
N-benzylpiperazine results in decreased expression of USP2 mRNA
CTD
PMID:26821219
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Wfdc2
WAP four-disulfide core domain 2
increases expression
EXP
N-benzylpiperazine results in increased expression of WFDC2 mRNA
CTD
PMID:26821219
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all